RMI-61140
RMI-61140 is an orally active neuroleptics. RMI-61140 decreases spontaneous motility and muscle tone in mice. RMI-61140 increases barbit urate-induced sleep and causes eyelid ptosis. RMI-61140 can be used for schizophrenia research[1].
Product Specifications
CAS Number
24140-98-5
UNSPSC
12352005
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/rmi-61140.html
Solubility
10 mM in DMSO
Smiles
OC(/C=C\C(O)=O)=O.ClC1=CC=C2OC3=CC=CC=C3C=C(N4CCN(CC4)C)C2=C1
Molecular Formula
C23H23ClN2O5
Molecular Weight
442.89
References & Citations
[1]Coscia L, et al. Pharmacological properties of new neuroleptic compounds. Arzneimittelforschung. 1975 Sep;25 (9) :1436-42.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1306500-01 0.02 mg (E-Coli)
Recombinant Xanthomonas oryzae pv. oryzae GTP cyclohydrolase folE2 (folE2)
Sign In for Pricing
View Details MBS1306500-02 0.02 mg (Yeast)
Recombinant Xanthomonas oryzae pv. oryzae GTP cyclohydrolase folE2 (folE2)
Sign In for Pricing
View Details MBS1306500-03 0.1 mg (E-Coli)
Recombinant Xanthomonas oryzae pv. oryzae GTP cyclohydrolase folE2 (folE2)
Sign In for Pricing
View Details